Body-Mass-Index
发表于 2025-3-21 18:02:01
书目名称Antiandrogens in Prostate Cancer影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0158381<br><br> <br><br>书目名称Antiandrogens in Prostate Cancer影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0158381<br><br> <br><br>书目名称Antiandrogens in Prostate Cancer网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0158381<br><br> <br><br>书目名称Antiandrogens in Prostate Cancer网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0158381<br><br> <br><br>书目名称Antiandrogens in Prostate Cancer被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0158381<br><br> <br><br>书目名称Antiandrogens in Prostate Cancer被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0158381<br><br> <br><br>书目名称Antiandrogens in Prostate Cancer年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0158381<br><br> <br><br>书目名称Antiandrogens in Prostate Cancer年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0158381<br><br> <br><br>书目名称Antiandrogens in Prostate Cancer读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0158381<br><br> <br><br>书目名称Antiandrogens in Prostate Cancer读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0158381<br><br> <br><br>
蜿蜒而流
发表于 2025-3-21 22:42:06
http://reply.papertrans.cn/16/1584/158381/158381_2.png
除草剂
发表于 2025-3-22 04:14:07
http://reply.papertrans.cn/16/1584/158381/158381_3.png
Altitude
发表于 2025-3-22 06:14:32
http://reply.papertrans.cn/16/1584/158381/158381_4.png
有其法作用
发表于 2025-3-22 12:42:18
http://reply.papertrans.cn/16/1584/158381/158381_5.png
我就不公正
发表于 2025-3-22 15:51:05
Einführung in die Phonologie und GraphematikNilutamide (RU 23908, Anandron.) is a nonsteroidal antiandrogen drug; its structure is presented in Figure 1. The pharmacodynamic and pharmacokinetic profiles are reviewed in this chapter.
天气
发表于 2025-3-22 20:32:20
http://reply.papertrans.cn/16/1584/158381/158381_7.png
标准
发表于 2025-3-22 21:34:12
http://reply.papertrans.cn/16/1584/158381/158381_8.png
暴发户
发表于 2025-3-23 02:43:08
Pharmacodynamics and Pharmacokinetics of Nilutamide in Animal and Man,Nilutamide (RU 23908, Anandron.) is a nonsteroidal antiandrogen drug; its structure is presented in Figure 1. The pharmacodynamic and pharmacokinetic profiles are reviewed in this chapter.
倔强一点
发表于 2025-3-23 06:08:15
https://doi.org/10.1007/978-3-7091-3516-7ield of prostate cancer, and scientists with a particular, specialised understanding of the endocrinology and biochemistry relevant to the use of these drugs. The aim of the meeting was to focus attention on the current knowledge regarding the mode of action of the antiandrogens and their use in the